Crossmark

Finding all BRCA pathogenic mutation carriers: best practice models

Crossref DOI link: https://doi.org/10.1038/ejhg.2016.95

Published Online: 2016-08-12

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hoogerbrugge, Nicoline

Jongmans, Marjolijn CJ
License Information

Text and Data Mining valid from 2016-08-12
More Information

Article History

First Online: 12 August 2016

Competing interests

: NH has received payments for consulting and speaker services from AstraZeneca and has attended advisory boards for AstraZeneca. She has also received grant support from AstraZeneca. MCJJ has declared no conflicts.